CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
58.78
+2.28 (4.04%)
At close: Mar 9, 2026, 4:00 PM EDT
56.53
-2.25 (-3.83%)
After-hours: Mar 9, 2026, 7:58 PM EDT
CRISPR Therapeutics AG Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5,642 | 4,998 | 3,360 | 4,972 | 3,183 | 5,799 | |
| Market Cap Growth | 37.29% | 48.76% | -32.44% | 56.24% | -45.12% | -46.39% | |
| Enterprise Value | 3,873 | 3,264 | 1,651 | 3,474 | 1,452 | 3,527 | |
| Last Close Price | 58.78 | 52.44 | 39.36 | 62.60 | 40.65 | 75.78 | |
| PE Ratio | - | - | - | - | - | 15.36 | |
| PS Ratio | 1607.41 | 1423.80 | 90.03 | 13.40 | 2656.64 | 6.34 | |
| PB Ratio | 2.93 | 2.60 | 1.74 | 2.64 | 1.70 | 2.42 | |
| P/TBV Ratio | 2.94 | 2.60 | 1.74 | 2.64 | 1.70 | 2.42 | |
| P/FCF Ratio | - | - | - | - | - | 12.68 | |
| P/OCF Ratio | - | - | - | - | - | 10.76 | |
| EV/Sales Ratio | 1103.40 | 930.04 | 44.26 | 9.36 | 1211.76 | 3.86 | |
| EV/EBITDA Ratio | - | - | - | - | - | 9.01 | |
| EV/EBIT Ratio | - | - | - | - | - | 9.44 | |
| EV/FCF Ratio | - | - | - | - | - | 7.71 | |
| Debt / Equity Ratio | 0.11 | 0.11 | 0.12 | 0.13 | 0.13 | 0.09 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.53 | |
| Debt / FCF Ratio | - | - | - | - | - | 0.49 | |
| Net Debt / Equity Ratio | -0.92 | -0.92 | -0.87 | -0.77 | -0.87 | -0.90 | |
| Net Debt / EBITDA Ratio | 3.22 | 3.22 | 3.76 | 7.19 | 2.50 | -5.50 | |
| Net Debt / FCF Ratio | 5.11 | 5.11 | 11.61 | 5.40 | 3.05 | -4.71 | |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.17 | 0 | 0.40 | |
| Quick Ratio | 13.25 | 13.25 | 21.97 | 17.47 | 15.08 | 19.92 | |
| Current Ratio | 13.32 | 13.32 | 22.07 | 17.54 | 15.30 | 20.17 | |
| Return on Equity (ROE) | -30.18% | -30.18% | -19.20% | -8.17% | -30.42% | 18.59% | |
| Return on Assets (ROA) | -15.76% | -15.76% | -13.04% | -6.22% | -16.85% | 10.20% | |
| Return on Invested Capital (ROIC) | -312.24% | -280.87% | -137.29% | -60.81% | -244.99% | 264.84% | |
| Return on Capital Employed (ROCE) | -26.90% | -26.90% | -21.70% | -10.50% | -31.70% | 14.20% | |
| Earnings Yield | -10.31% | -11.64% | -10.90% | -3.09% | -20.43% | 6.51% | |
| FCF Yield | -6.13% | -6.92% | -4.31% | -5.43% | -16.74% | 7.89% | |
| Buyback Yield / Dilution | -6.60% | -6.60% | -6.49% | -1.90% | 3.29% | -21.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.